Compare HOUR & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | HYFT |
|---|---|---|
| Founded | 2015 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.5M | 84.0M |
| IPO Year | 2022 | 2017 |
| Metric | HOUR | HYFT |
|---|---|---|
| Price | $1.75 | $1.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.7K | ★ 741.6K |
| Earning Date | 11-12-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $140,790,433.00 | $19,019,110.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | $73.69 | ★ N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $1.10 | $0.27 |
| 52 Week High | $6.84 | $3.25 |
| Indicator | HOUR | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 37.39 |
| Support Level | $1.71 | $1.85 |
| Resistance Level | $1.87 | $2.39 |
| Average True Range (ATR) | 0.04 | 0.22 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 55.50 | 7.41 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.